Biotech Innovations CAR T-Cell Therapy Shows Early Promise for Gastrointestinal Cancer

被引：1
|
作者：
Larkin, Howard D.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 22期
关键词：
D O I：
10.1001/jama.2022.9511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2182 / 2182
页数：1
相关论文
共 50 条
  • [31] CAR T-cell therapy for gastric cancer: Potential and perspective (Review)
    Long, Bo
    Qin, Long
    Zhang, Boya
    Li, Qiong
    Wang, Long
    Jiang, Xiangyan
    Ye, Huili
    Zhang, Genyuan
    Yu, Zeyuan
    Jiao, Zuoyi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (04) : 889 - 899
  • [32] Hurdles race for CAR T-cell therapy in digestive tract cancer
    Kronig, Marie-Noelle
    Wehrli, Marc
    Salas-Benito, Diego
    Maus, Marcela V.
    IMMUNOLOGICAL REVIEWS, 2023, 320 (01) : 100 - 119
  • [33] CAR-modified T-cell therapy for cancer: an updated review
    Haji-Fatahaliha, Mostafa
    Hosseini, Maryam
    Akbarian, Asiye
    Sadreddini, Sanam
    Jadidi-Niaragh, Farhad
    Yousefi, Mehdi
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (06) : 1339 - 1349
  • [34] Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
    Aparicio, Cristina
    Belver, Marina
    Enriquez, Lucia
    Espeso, Francisco
    Nunez, Lucia
    Sanchez, Ana
    de la Fuente, Miguel angel
    Gonzalez-Vallinas, Margarita
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [35] CD4+CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy
    Ledergor, Guy
    Fan, Zenghua
    Wu, Kai
    Mccarthy, Elizabeth
    Hyrenius-Wittsten, Axel
    Starzinski, Alec
    Chang, Hewitt
    Bridge, Mark
    Kwek, Serena
    Cheung, Alexander
    Bylsma, Sophia
    Hansen, Erik
    Wolf, Jeffrey
    Wong, Sandy
    Shah, Nina
    Roybal, Kole T.
    Martin, Thomas
    Ye, Chun J.
    Fong, Lawrence
    BLOOD ADVANCES, 2024, 8 (13) : 3562 - 3575
  • [36] The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
    Abou-el-Enein, Mohamed
    BLOOD CANCER DISCOVERY, 2024, 5 (04): : 249 - 257
  • [37] Hypogammaglobulinemia due to CAR T-cell therapy
    Pulsipher, Michael A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (04)
  • [38] CAR T-Cell Therapy: An Update for Radiologists
    Yoon, Justin G.
    Smith, Daniel A.
    Tirumani, Sree H.
    Caimi, Paolo F.
    Ramaiya, Nikhil H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (06) : 1461 - 1474
  • [39] CAR T-cell Therapy for Thoracic Cancers
    Adusumilli, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S828 - S828
  • [40] Toxicity and management in CAR T-cell therapy
    Bonifant, Challice L.
    Jackson, Hollie J.
    Brentjens, Renier J.
    Curran, Kevin J.
    MOLECULAR THERAPY-ONCOLYTICS, 2016, 3 : 16011
12345